Novartis has filed a lawsuit against the state of Maryland seeking to block a new law that mandates drugmakers to offer discounts on medications dispensed by third-party pharmacies which contract with hospitals and clinics serving low-income populations. The pharmaceutical giant argues that the Maryland law conflicts with federal law and the 340B drug discount program. Novartis has requested a U.S. judge to intervene and prevent the enforcement of this state legislation.
Novartis asked a US judge to block a Maryland law that would require drugmakers to offer discounts through third-party clinics that contract with hospitals and clinics serving low-income populations. Subscribe to The Daily Docket: https://t.co/s1z0JFig0G https://t.co/AS0XGQ4YdT
Novartis has sued Maryland over a law that would require drugmakers to offer discounts through third-party clinics contracting with hospitals and clinics serving low-income populations. The lawsuit said the law conflicted with federal law https://t.co/J3QZMSTXSC https://t.co/S2DikcSJZz
Novartis sues Maryland over law mandating discounts for hospitals' outside pharmacies https://t.co/7FjI0OHmRv https://t.co/1NtK2WlN1w
Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program. https://t.co/cFRl47z0Av
Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program.. https://t.co/WAESp33g3t #pharma #340B #pharmacies #medicines #drugs #Maryland $NVS $AZN
Novartis has filed a lawsuit seeking to block a Maryland law that would require drugmakers to offer discounts on drugs dispensed by third-party pharmacies that contract with hospitals and clinics serving low-income populations https://t.co/BvJHkXqbZ1 @brenpiers https://t.co/fjVcVR8gZL